Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN657229 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Forkhead Box O3 (FOXO3) (N-Term), (AA 1-30) antibody
- Antibody type
- Polyclonal
- Antigen
- This FOXO3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 AA from the N-terminal region of human FOXO3.
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term,AA 1-30
- Antibody clone number
- RB33291
- Vial size
- 400 μL
- Concentration
- 0.5 mg/mL
Submitted references An approach based on a genome-wide association study reveals candidate loci for narcolepsy.
Vitamin D3 up-regulated protein 1(VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts.
Molecular architecture of the DNA replication origin activation checkpoint.
FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma.
Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, Tokunaga K
Human genetics 2010 Oct;128(4):433-41
Human genetics 2010 Oct;128(4):433-41
Vitamin D3 up-regulated protein 1(VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts.
Zhuo de X, Niu XH, Chen YC, Xin DQ, Guo YL, Mao ZB
The Journal of biological chemistry 2010 Oct 8;285(41):31491-501
The Journal of biological chemistry 2010 Oct 8;285(41):31491-501
Molecular architecture of the DNA replication origin activation checkpoint.
Tudzarova S, Trotter MW, Wollenschlaeger A, Mulvey C, Godovac-Zimmermann J, Williams GH, Stoeber K
The EMBO journal 2010 Oct 6;29(19):3381-94
The EMBO journal 2010 Oct 6;29(19):3381-94
FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma.
Mikse OR, Blake DC Jr, Jones NR, Sun YW, Amin S, Gallagher CJ, Lazarus P, Weisz J, Herzog CR
Cancer research 2010 Aug 1;70(15):6205-15
Cancer research 2010 Aug 1;70(15):6205-15
No comments: Submit comment
No validations: Submit validation data